---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-21-000110"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2021-07-22T23:59:59+00:00"
generated_at: "2026-06-30T03:14:44.526925+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions expands Adam Havey to EVP and COO effective July 26

## Summary
- Adam Havey appointed Executive Vice President and Chief Operating Officer on July 20, 2021, effective July 26.
- Havey, 50, joined Emergent in 2003 and previously served as EVP Business Operations since April 2017.
- Reorganization of executive team approved by Board; Havey becomes principal operating officer.
- He will oversee expanded responsibilities as part of the CEO's proposed restructuring.

## SEC filing metadata
- accession: 0001367644-21-000110
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2021-07-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000110/0001367644-21-000110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000110/ebs-20210720.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-21-000110
- JSON: https://secwatch.observer/filing/0001367644-21-000110.json
- Plain text: https://secwatch.observer/filing/0001367644-21-000110.txt

## Key facts
- Executive change
  Adam Havey changed role as Executive Vice President and Chief Operating Officer at Emergent BioSolutions Inc..
  - Action: expanded
  - Role: Executive Vice President and Chief Operating Officer
  source text: In connection with that reorganization, Adam Havey’s role is expanded to Executive Vice President and Chief Operating Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000110/0001367644-21-000110-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.